BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 12105776)

  • 1. Successful treatment of relapsed blastic natural killer cell lymphoma with unrelated cord blood transplantation.
    Yoshimasu T; Manabe A; Tanaka R; Mochizuki S; Ebihara Y; Ishikawa K; Iseki T; Oyaizu N; Aritaki K; Tanaka K; Tsuruta T; Hoshika A; Asano S; Tsuji K
    Bone Marrow Transplant; 2002 Jul; 30(1):41-4. PubMed ID: 12105776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term remission of blastic natural killer-cell lymphoma after autologous peripheral blood stem-cell transplantation.
    Yamaguchi M; Maekawa M; Nakamura Y; Ueda M
    Am J Hematol; 2005 Oct; 80(2):124-7. PubMed ID: 16184583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complete remission in advanced blastic NK-cell lymphoma/leukemia in elderly patients using the hyper-CVAD regimen.
    Shapiro M; Wasik MA; Junkins-Hopkins JM; Rook AH; Vittorio CC; Itakura H; Frankel MC; Georgala S; Schuster SJ
    Am J Hematol; 2003 Sep; 74(1):46-51. PubMed ID: 12949889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of disseminated nasal NK/T-cell lymphoma using double autologous peripheral blood stem cell transplantation.
    Sasaki M; Matsue K; Takeuchi M; Mitome M; Hirose Y
    Int J Hematol; 2000 Jan; 71(1):75-8. PubMed ID: 10729998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of adult T-cell leukemia with unrelated cord blood transplantation.
    Takizawa J; Aoki S; Kurasaki T; Higashimura M; Honma K; Kitajima T; Momoi A; Takahashi H; Nakamura N; Furukawa T; Aizawa Y
    Am J Hematol; 2007 Dec; 82(12):1113-5. PubMed ID: 17696205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [High-dose chemotherapy with autologous hematopoietic stem cell transplantation for non-Hodgkin's lymphoma in complete response as consolidation therapy, second report].
    Yamane T; Hirose A; Nakajima Y; Nakane T; Koh H; Takeoka Y; Nakamae M; Yamamura R; Nakamae H; Nakao Y; Mugitani A; Yagi T; Teshima H; Hino M
    Gan To Kagaku Ryoho; 2006 Feb; 33(2):193-8. PubMed ID: 16484855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective high-dose chemotherapy combined with CD34+-selected peripheral blood stem cell transplantation in a patient with cutaneous involvement of nasal NK/T-cell lymphoma.
    Koizumi K; Fujimoto K; Haseyama Y; Endo T; Nishio M; Yokota K; Itoh T; Sawada K; Koike T
    Eur J Haematol; 2004 Feb; 72(2):140-4. PubMed ID: 14962252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic haematopoietic stem cell transplantation as a promising treatment for natural killer-cell neoplasms.
    Murashige N; Kami M; Kishi Y; Kim SW; Takeuchi M; Matsue K; Kanda Y; Hirokawa M; Kawabata Y; Matsumura T; Kusumi E; Hirabayashi N; Nagafuji K; Suzuki R; Takeuchi K; Oshimi K
    Br J Haematol; 2005 Aug; 130(4):561-7. PubMed ID: 16098071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unrelated bone marrow transplantation for Epstein-Barr virus-associated T/NK-cell lymphoproliferative disease.
    Okamura T; Kishimoto T; Inoue M; Honda M; Yamashita N; Wakiguchi H; Yagita M; Hosoi G; Sako M; Yasui M; Yagi K; Kawa K
    Bone Marrow Transplant; 2003 Jan; 31(2):105-11. PubMed ID: 12621491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematopoietic stem cell transplantation for natural killer-cell lineage neoplasms.
    Suzuki R; Suzumiya J; Nakamura S; Kagami Y; Kameoka JI; Sakai C; Mukai H; Takenaka K; Yoshino T; Tsuzuki T; Sugimori H; Kawa K; Kodera Y; Oshimi K;
    Bone Marrow Transplant; 2006 Feb; 37(4):425-31. PubMed ID: 16400344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Midline NK/T-cell lymphoma nasal-type: treatment outcome, the effect of L-asparaginase based regimen, and prognostic factors.
    Yong W; Zheng W; Zhu J; Zhang Y; Wei Y; Wang X; Lin N; Xie Y; Xu B; Li J
    Hematol Oncol; 2006 Mar; 24(1):28-32. PubMed ID: 16323259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myelodysplastic syndrome of donor origin subsequent to successful treatment of myeloid/NK-cell precursor leukaemia with allogeneic PBSCT: two very rare conditions in one patient.
    Beck C; Humpe A; Harder S; Schmid M; Horst HA
    Ann Hematol; 2005 Sep; 84(9):616-8. PubMed ID: 15782344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Childhood blastic NK cell leukemia successfully treated with L-asparagenase and allogeneic bone marrow transplantation.
    Hyakuna N; Toguchi S; Higa T; Okudaira T; Taira N; Masuda M; Kitoh T; Ohta T
    Pediatr Blood Cancer; 2004 Jun; 42(7):631-4. PubMed ID: 15127419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prognostic analysis of patients with nasal-type NK/T-cell non-Hodgkin's lymphoma--a report of 93 cases].
    Pan ZH; Huang HQ; Lin XB; Xia YF; Xia ZJ; Peng YL; Cai QQ; Lin TY; Jiang WQ; Guan ZZ
    Ai Zheng; 2005 Dec; 24(12):1493-7. PubMed ID: 16351799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of advanced extranodal NK/T cell lymphoma with unrelated cord blood transplantation.
    Yokoyama H; Yamada MF; Ishizawa K; Yamamoto J; Tomiya Y; Harigae H; Kameoka J; Ichinohasama R; Sasaki T
    Tohoku J Exp Med; 2007 Apr; 211(4):395-9. PubMed ID: 17409680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of risk factors for outcomes after unrelated cord blood transplantation in adults with lymphoid malignancies: a study by the Eurocord-Netcord and lymphoma working party of the European group for blood and marrow transplantation.
    Rodrigues CA; Sanz G; Brunstein CG; Sanz J; Wagner JE; Renaud M; de Lima M; Cairo MS; Fürst S; Rio B; Dalley C; Carreras E; Harousseau JL; Mohty M; Taveira D; Dreger P; Sureda A; Gluckman E; Rocha V
    J Clin Oncol; 2009 Jan; 27(2):256-63. PubMed ID: 19064984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term disease-free survival in patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation.
    Schetelig J; Fetscher S; Reichle A; Berdel WE; Beguin Y; Brunet S; Caballero D; Majolino I; Hagberg H; Johnsen HE; Kimby E; Montserrat E; Stewart D; Copplestone A; Rösler W; Pavel J; Kingreen D; Siegert W
    Haematologica; 2003 Nov; 88(11):1272-8. PubMed ID: 14607756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment outcome and prognosis of autologous hematopoietic stem cell transplantation combined with high dose radiotherapy/chemotherapy in 22 patients with nasal NK/T cell lymphoma].
    Cui XZ; Wang HQ; Liu XM; Zhang HL; Li W
    Zhonghua Xue Ye Xue Za Zhi; 2007 Sep; 28(9):609-11. PubMed ID: 18246818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disappointing outcome of autologous stem cell transplantation for enteropathy-associated T-cell lymphoma.
    Al-Toma A; Verbeek WH; Visser OJ; Kuijpers KC; Oudejans JJ; Kluin-Nelemans HC; Mulder CJ; Huijgens PC
    Dig Liver Dis; 2007 Jul; 39(7):634-41. PubMed ID: 17531561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of disseminated nasal T-cell lymphoma using high-dose chemotherapy and autologus peripheral blood stem cell transplantation: a case report.
    Kouzaki H; Kitanishi T; Kitano H; Suzuki M
    Auris Nasus Larynx; 2004 Mar; 31(1):79-83. PubMed ID: 15041059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.